Navigation Links
Waters Corporation and UCLA to Convene Leading Life Scientists
Date:9/3/2010

MILFORD, Mass., Sept. 3 /PRNewswire/ -- Waters Corporation (NYSE: WAT) and the University of California at Los Angeles (UCLA) will bring together some of the world's leading life science researchers and practitioners of mass spectrometry (MS) at a conference next month to discuss the ways they are applying time-of-flight mass spectrometry to complex biomolecule research and analysis. Waters today announced the agenda and presentation topics for the Applications of Time of Flight Mass Spectrometry Conference, which will held at The Queen Mary in Long Beach, California, from September 13-15.

"This meeting provides an excellent platform for review and discussion of the most current theories and applications in time-of-flight mass spectrometry," said Brian Smith, V.P. Mass Spectrometry Operations, Waters Division.  "The conference will bring together leaders with specialties in areas such as proteomics, chemistry and pharmacology, all of whom are gathering to share ideas and advance research."

Meeting attendees and presenters hail from some of the most prestigious academic and industrial laboratories.  Twenty-five presentations will be given on topics such as quantitative proteomics, drug discovery, probing protein conformation, protein complexes, metabolites, lipids and glycoproteins.

Waters scientists are presenting at the Applications of Time of Flight Mass Spectrometry Conference.  Copies of their presentations will be available for downloading from the Waters website shortly after the meeting concludes.

  • Practical and Theoretical Constraints upon System-wide Protein Quantification by LC-MS , James Langridge
  • Characterization of Protein Therapeutics by Ion-mobility Time-of-flight Mass Spectromet
    '/>"/>

SOURCE Waters Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Waters Brings Advanced Laboratory Data Management to Microsofts BioIT Alliance
2. David H. Murdock Research Institute Taps Waters for Laboratory Technology
3. Waters Publishes Rapid and Specific Method of Detection for Melamine in Infant Formula and Liquid Milk, in Support of Chinas Ministry of Science and Technology
4. Waters Corporation Gives Boost to Clinical Research Programs at University of Sherbrooke Hospital
5. Waters New ACQUITY UPLC Online Community Attracts More Than 1,200 Members in First Month
6. XenoTech LLC Offers Drug Industry New Metabolite Profiling Services Following Acquisition of Waters Synapt HDMS System
7. USDA Boosts Food Safety Research with Purchase of Waters ACQUITY TQD System
8. Waters Corporation Continues to Meet Todays Challenges for Improved Laboratory Operations with New Products at Pittcon 2009
9. Waters and University of Warwick Sign Research Agreement Designed to Foster Adoption of Novel MS Technologies
10. Waters Introduces New SYNAPT G2 with Greater Power, Versatility and Speed Than Any Other High-End Mass Spectrometer
11. First ASMS Hites Award for Outstanding Research Publication Presented to Prof. Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Protein Complexes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2012)... First tenant moves in Stevenage Bioscience Catalyst ... to announce that it is now open for business. In ... , which has taken space in the Incubator building. SBC ... one - discussions with a range of interesting tenants are ... and events focused on rejuvenation of the UK biosciences sector. ...
(Date:2/8/2012)...  Neuralstem, Inc. (NYSE Amex: CUR ... will present at the 14th Annual BIO CEO ... on Monday, February 13, at 3:00 p.m. EST. ... update on the company,s ongoing clinical trials in ... (Logo:  http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) ...
(Date:2/6/2012)... shimmer in the light like the scales on ... color-change components of a revolutionary new approach to ... in International Journal of Design Engineering . ... GmbH in Austria are working with Roland Palkovits ... Neustadt, to develop a nanoparticle microfluidic color device ...
(Date:2/6/2012)... Texas, Feb. 6, 2012 Dietary supplements ... government regulations in the United States, according to ... Botanical Council (ABC). The article notes ... granted to the U.S. Food and Drug Administration ... well as other government agencies. (Logo: ...
Breaking Biology Technology:Stevenage Bioscience Catalyst Opens With Exciting Year Ahead 2Stevenage Bioscience Catalyst Opens With Exciting Year Ahead 3Stevenage Bioscience Catalyst Opens With Exciting Year Ahead 4Stevenage Bioscience Catalyst Opens With Exciting Year Ahead 5Stevenage Bioscience Catalyst Opens With Exciting Year Ahead 6Neuralstem President and CEO to Present at BIO CEO & Investor Conference 2012 2Neuralstem President and CEO to Present at BIO CEO & Investor Conference 2012 3The butterfly effect in nanotech medical diagnostics 2Dietary Supplements Extensively Regulated, Say Authors of New Article 2Dietary Supplements Extensively Regulated, Say Authors of New Article 3Dietary Supplements Extensively Regulated, Say Authors of New Article 4Dietary Supplements Extensively Regulated, Say Authors of New Article 5
... Brookfield-based Fiserv Inc. has unveiled a program of ... financial processing and health-plan administration. , ,Spurred ... healthcare banking is a set of services which ... moving payments between parties in healthcare transactions. , ...
... medical business struggles with the problems of clinical risks and ... through the use of war-game exercises, in which scenarios that ... can be simulated in the course of hours and allow ... they can pose a real threat. , ,While simulations have ...
... Bone Care International Inc. announced on Wednesday that the U.S. ... and Bone Care have signed a definitive agreement for Genzyme ... valued at $33.00 per fully diluted share. The ... shareholders at a meeting on June 30, and other customary ...
Other Biology Technology:Medical simulations identify potential problems before they can pose a real threat 2Medical simulations identify potential problems before they can pose a real threat 3
(Date:2/10/2012)... SAN DIEGO, Feb. 10, 2012  Trovagene, ... transrenal molecular diagnostics, has announced that Stephen ... Mr. Zaniboni,s experience includes ... financing and IPO proceeds.  Mr. Zaniboni previously served as ... company Awarepoint and XIFIN Inc., a provider ...
(Date:2/9/2012)... type 2 diabetes (T2D) has identified new gene ... disease. An international scientific consortium, studying multiethnic populations, ... for developing more effective drugs for T2D. , ... which affects nearly 300 million people worldwide. The ... "Scientists have identified only about 10 percent ...
(Date:2/9/2012)... bacteria infect a human host, cells of various ... address the threat. , In new research appearing ... Nature Immunology , Roy Curtiss, director of the ... Biodesign Institute at Arizona State University, along with ... type of immune response, involving the release of ...
Breaking Biology News(10 mins):Stephen Zaniboni Joins Trovagene, Inc. as Chief Financial Officer 2Stephen Zaniboni Joins Trovagene, Inc. as Chief Financial Officer 3Largest-ever gene study of Type 2 diabetes finds variants across many ethnic groups 2Secrets of immune response illuminated in new study 2Secrets of immune response illuminated in new study 3Secrets of immune response illuminated in new study 4Consumer Group Responds to Governor Schwarzeneggers Incorrect Claims About the Impact of Medical Malpractice Caps 60361 1Consumer Group Responds to Governor Schwarzeneggers Incorrect Claims About the Impact of Medical Malpractice Caps 60361 2Consumer Group Responds to Governor Schwarzeneggers Incorrect Claims About the Impact of Medical Malpractice Caps 60361 3Violence Prevention Advocate Dan Monez Expanding San Diego Company Up North 60358 1Violence Prevention Advocate Dan Monez Expanding San Diego Company Up North 60358 2Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 1Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 2Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 3
... climate change, pollution and human activity. ESA,s ERS and ... region for the last 17 years. These long term ... be key in implementing the newly adopted European Commission ... , The policy highlights new opportunities in the region ...
... levels in fish are prompting widespread consumption advisories and ... eat. Now researchers at North Carolina State University have ... around the country predict which areas are likely to ... that should help officials address public uncertainty by developing ...
... hold a colloquium to examine what lies ahead in ... Leading researchers and students will discuss new tools to ... the perspectives of ecology, paleontology, phylogenetics, and biodiversity informatics ... Sackler Colloquium series, the event will take place at ...
Other Biology News:ESA satellites focusing on the Arctic 2New model predicts hot spots for mercury in fish 2
... Xcise is a powerful technology platform that ... analysis. High quality sample preparation can ... , The Xcise is a powerful technology ... throughput proteome analysis. It combines the functions ...
Extra Large bottle for hybridization 300 x 70mm...
Request Info...
... The Thermo IEC Microtube Rotor is ... have to change rotors. You can ... and PCR tubes. Exclusive polypropylene rotor design ... repeatedly autoclaved. Polypropylene rotors are fully ...
Biology Products: